Medpace
Page Module:Infobox/styles.css has no content.Page Template:Infobox company/styles.css has no content.
| Lua error in package.lua at line 80: module 'Module:InfoboxImage/data' not found. | |
| Formerly | Medical Research Services (1992-bef.2014) |
|---|---|
Company type | Public |
| Page Template:Plainlist/styles.css has no content. | |
| ISIN | Script error: No such module "WikidataIB". |
| Industry | Script error: No such module "WikidataIB". |
| Predecessor | Script error: No such module "WikidataIB". |
| Incorporated | Script error: No such module "WikidataIB". |
| Founded | Script error: No such module "WikidataIB". |
| Founder | Script error: No such module "WikidataIB". |
| Defunct | Script error: No such module "WikidataIB". |
| Successor | Script error: No such module "WikidataIB". |
| Headquarters | Cincinnati, Ohio, U.S. |
Area served |  Over 40 countries (2023)[1] |
Key people | August J. Troendle (CEO & chairman of the board of directors) |
| Products | Support services for pharmaceutical, biotech, and medical device companies |
| Revenue | Script error: No such module "WikidataIB". |
| Script error: No such module "WikidataIB". | |
| Script error: No such module "WikidataIB". | |
| Total assets | Script error: No such module "WikidataIB". |
Number of employees | Script error: No such module "WikidataIB". |
| Parent | Script error: No such module "WikidataIB". |
| Website | medpace |
Script error: No such module "Check for conflicting parameters".Script error: No such module "Check for deprecated parameters".
Medpace Holdings, Inc. is a global clinical research organization (CRO) based in Cincinnati, Ohio,[2][1][3] employing approximately 6,000 people. Operating under a full-service model, the company also offers global central laboratory, imaging core laboratory, and bioanalytical laboratory services, as well as a Phase I unit located on its headquarters and clinical research campus in Cincinnati, Ohio.
The company started trading stock as a public firm in 2016.
History
August Troendle founded Medpace in Cincinnati, Ohio, in 1992 as Medical Research Services.[4] Troendle first became interested in the CRO sector after working in both the regulatory and pharmaceutical area. He began his career as a reviewer with the FDA, specializing in the development of lipid lowering therapies to treat high cholesterol.
With a team of industry physicians, Jonathan Issacsohn and Evan Stein completed many early studies while at Medpace and Medpace Reference Laboratories on the use of statin therapies for the treatment of hypercholesterolemia.[5] Another Medpace physician, David Orloff was regarded as an industry opinion leader in the study of metabolic diseases – most specifically diabetes and obesity.[6] Troendle was honored for his work as a Medpace founder in 2012 by the Cincinnati Chamber of Commerce.[7]
Medpace completed construction on a new campus in 2012 in Madisonville, a neighborhood on the eastern side of Cincinnati.[8] The project encompassed revitalizing an urban brownfield site formerly occupied by NuTone, and creating a state of the art LEED (Leadership in Energy and Environmental Design) certified campus.[9]
In 2022, Medpace announced a $150 million capital investment to expand its headquarters in Cincinnati, Ohio, adding an estimated expansion of 1,500 new jobs.
Acquisitions
- 2007 – Medpace acquires Monax in the Czech Republic[10]
- 2009 – Medpace acquires PharmaBrains AG in Switzerland
- 2010 – Medpace acquires Symbios, a medical device consultancy in Minneapolis, Minnesota[11]
- 2010 – Medpace acquires Medical Consulting Dr. Schlichtiger, GmbH, in Germany[12]
- 2012 – Medpace acquires MediTech BV, a medical device consultancy in the Netherlands.[13]
Ownership
In 2011, CCMP Capital acquired 80% of the firm for Template:US$.[14] Three years later, in February 2014, CCMP auctioned their 80% stake; the winner was won by Cinven, who paid Template:US$.[4][14] In August 2017, Medpace went became a publicly traded company with its initial public offering, selling 8,050,000 shares of common stock.[4]
Corporate affairs
Head Office Locations
Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio, United States. The company’s main campus, known as the Medpace Campus, is located in the Madisonville neighborhood of Cincinnati and includes multiple office buildings, laboratories, and clinical facilities.[15]
In addition to its headquarters, Medpace operates regional offices and clinical sites across North America, Europe, Asia, and Latin America to support global clinical trial operations.[16]
Financial performance
Medpace Holdings, Inc. has demonstrated strong revenue and income growth since going public in 2016, maintaining a steady upward trajectory in operating and net income over the last several years.[17]
| Year | Revenue (USD billion) |
Gross Profit (USD billion) |
Net Income (USD billion) |
|---|---|---|---|
| 2013 | 0.27 | 0.12 | 0.02 |
| 2015 | 0.36 | 0.15 | -0.08 |
| 2017 | 0.43 | 0.17 | 0.04 |
| 2020 | 0.93 | 0.28 | 0.14 |
| 2021 | 1.14 | 0.33 | 0.18 |
| 2022 | 1.46 | 0.43 | 0.24 |
| 2023 | 1.89 | 0.52 | 0.28 |
| 2024 | 2.11 | 0.66 | 0.40 |
Further reading
- Page Module:Citation/CS1/styles.css has no content.Watkins, Steve (29 June 2018). "Which Cincinnati public company CEO delivers the best bang for the buck? (Video)". Cincinnati Business Courier. American City Business Journals. Retrieved 31 Aug 2019.
It's rare to see a CEO make less money than a CFO or an executive vice president. But that's how it worked last year at Medpace Holdings Inc....
References
Page Template:Reflist/styles.css has no content.
- ^ a b c d Page Module:Citation/CS1/styles.css has no content.Aycock, Jason (24 June 2016). "Medpace Holdings files to raise up to $150M in IPO". Seeking Alpha. Retrieved 2016-06-26.
- ^ Page Module:Citation/CS1/styles.css has no content.Vinluan, Frank (14 June 2011). "Mid-sized CROs perform as good or better than larger ones, survey says". MedCity News. New York, New York: Breaking Media. Retrieved 31 Aug 2019.
The strong performance of mid-sized CROs was evident in the category for speed of site and investigator recruitment. Cincinnati, Ohio-based MedPace was the highest scoring CRO in survey responses for that category while large CROs such as Covance, Parexel, PPD, PRA International and Quintiles all received negative marks.
- ^ Page Module:Citation/CS1/styles.css has no content."S-1". EDGAR. 24 June 2016. Retrieved 2016-06-26.
- ^ a b c Page Module:Citation/CS1/styles.css has no content.Brunsman, Barrett J. (22 August 2016). "Cincinnati CEO buys $20M worth of stock in IPO". Cincinnati Business Courier. American City Business Journals. Retrieved 31 Aug 2019.
After the Aug. 16 transaction, Troendle directly owned more than 1.2 million shares of Medpace.
- ^ Page Module:Citation/CS1/styles.css has no content.Jonathan Isaacsohn M.D., William Insull JR., M.D., Evan Stein M.D.Ph.D., Peter Kwiterovich M.D., Ma Patrick M.D., Ronald Brazg M.D., Carlos A. Dujovne M.D., Michael Shan PH.D., Elizabeth Shugrue-Crowley B.S., Steven Ripa M.D., Robert Tota M.D. (September 2001). "Long-Term Efficacy and Safety of Cerivastatin 0.8 mg in Patients with Primary Hypercholesterolemia". Clinical Cardiology. 24 (Supplement S4): IV1-9. doi:10.1002/clc.4960240902. PMC 6655191. PMID 11594407.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - ^ Page Module:Citation/CS1/styles.css has no content.Orloff, David. "Interview with Dr. David Orloff". August 23, 2011. Pharmaceutical Business Review. Retrieved 10 April 2013.
- ^ Page Module:Citation/CS1/styles.css has no content.Hirt, Amy. "Courier Contributor". Cincinnati Business Courier. The Business Journals Digital Network. Retrieved 9 April 2013.
- ^ Page Module:Citation/CS1/styles.css has no content."Medpace Construction Ranks 3rd behind downtown mega projects". April 2010. Retrieved 10 April 2013.
- ^ Page Module:Citation/CS1/styles.css has no content."Brownfield Redevelopment". cincinnati-oh.gov. Archived from the original on 28 August 2013. Retrieved 9 April 2013.
- ^ Page Module:Citation/CS1/styles.css has no content."Medpace acquires Czech CRO". Pharma Times. 22 August 2007. Retrieved 10 April 2013.
- ^ Page Module:Citation/CS1/styles.css has no content."Medpace acquires Symbios Clinical". April 8, 2010. Pharmacy News EU. Retrieved 11 April 2013.
- ^ Page Module:Citation/CS1/styles.css has no content."Medpace acquires European CRO". January 2010. Retrieved 10 April 2013.
- ^ Page Module:Citation/CS1/styles.css has no content.Morrison, Natalie (20 November 2012). "Medpace boost EU device offering through Meditech takeover". Outsourcing Pharma. Retrieved 11 April 2013.
- ^ a b Page Module:Citation/CS1/styles.css has no content.Roumeliotis, Greg (23 February 2014). "Cinven to acquire Medpace in $900 million deal: sources". Reuters. Retrieved 31 Aug 2019.
- ^ Page Module:Citation/CS1/styles.css has no content."Medpace Global Headquarters". Medpace. Retrieved 16 August 2025.
- ^ Page Module:Citation/CS1/styles.css has no content."Medpace Global Locations". Medpace. Retrieved 16 August 2025.
- ^ Page Module:Citation/CS1/styles.css has no content."Medpace Holdings, Inc. Financials". Smartfin. Retrieved 16 August 2025.
External links
- Official website
- Business data for Medpace Holdings, Inc.: Page Template:Hlist/styles.css has no content.
Template:Contract research organization Template:S&P 400 companies Lua error in package.lua at line 80: module 'Module:Authority control/config' not found.
